Dechra Pharmaceuticals PLC

DPHAY · OTC
Analyze with AI
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Operating Activities
Net Income$6$96$84$52
Dep. & Amort.$90$89$16$14
Deferred Tax$11-$40-$55-$28
Stock-Based Comp.-$1$3$3$2
Change in WC-$60-$28-$36-$9
Other Non-Cash$18$2$78$76
Operating Cash Flow$64$123$89$106
Investing Activities
PP&E Inv.-$30-$78-$135-$49
Net Acquisitions-$397-$1-$2-$33
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$1$0$0$1
Investing Cash Flow-$426-$78-$136-$82
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$182$2$2$132
Stock Repurch.-$15$1$14$140
Dividends Paid-$52-$45-$38-$33
Other Fin. Act.$368-$1-$17$152
Financing Cash Flow$317-$46-$55$119
Forex Effect-$0$4-$7$3
Net Chg. in Cash-$47$3-$109$147
Supplemental Information
Beg. Cash$121$118$227$80
End Cash$74$121$118$227
Free Cash Flow$33$45-$46$57